In this downloadable slideset, CCO’s expert faculty summarize emerging data on HBV management and treatment, discuss progress on identifying risk for hepatocellular carcinoma, and examine emerging trends in HCV treatment outcomes.
Hear insights from Norah Terrault, MD, MPH, on some of the most important viral hepatitis data reported at the virtual American Association for the Study of Liver Diseases (AASLD) 2020 annual meeting, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations.
Join me on a review of several interesting HBV studies from AASLD 2020 Virtual for my thoughts on how these data may affect clinical practice.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.